跳至主要内容
临床试验/NCT02934763
NCT02934763Unknown4 期

Opioid Induced Hyperalgesia (OIH) Modulation With Propranolol, in Laparoscopic Abdominal Surgery

Pontificia Universidad Catolica de Chile0 个研究点目标入组 80 人开始时间: 2016年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
80
主要终点
Postoperative opioid use

研究概览

简要总结

Opioid Induced Hyperalgesia (OIH) is an entity than has been demonstrated in healthy volunteers and in animal models. Is defined as an increase in the perception to painful stimuli, increasing the opioid requirements and diminishing the pain thresholds to stimuli.

The apparition of OIH is also related to the exposure to opioids during surgery, depending of the dose, the time of exposition and the type of opioid.

This condition can be modulated, specially in the perioperative context. It has been seen in healthy volunteers and in animal models, than the use of propranolol can modulate this phenomena, diminishing the postoperative requirements of analgesia. It is also unknown, the dose of propranolol required to modulate adequately OIH.

The objective of this work is to evaluate the efficacy of propranolol in the modulation of opioid induced hyperalgesia, with lower postoperative requirements of analgesia rescue.

详细描述

This is a randomized controlled study, comparing 2 interventions with a placebo. The interventions will be use of propranolol, at different doses, to achieve specific plasmatic concentrations.

80 patients will be required to find a difference of 20% in the primary outcome.

The primary outcome to be measured is the postoperative use of opioids in the post anesthesic care unit.

Secondary outcomes, will be the amount of opioids used in the following 24 hours to the surgery, the time to the first dose of analgesia in the post anesthesic care unit, and the change in the pain thresholds, evaluated as pain by pressure and by tactile sensitivity, before and after surgery.

Also, as a secondary outcome, in a group than will not receive the study drug, we will evaluate the temporal changes in opioid induced hyperalgesia, by pain sensitivity measured in the postoperative hours 2, 4 and 24. 10 patients receiving placebo will be part of this additional measures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for elective laparoscopic cholecystectomy
  • American Society of Anesthesiology Score (ASA) I-II

排除标准

  • Medical history of cardiac disease
  • Medical history of respiratory disease
  • Regular use of beta blockers
  • Known allergies to drugs used in the study
  • Known history of illicit drugs use

研究组 & 干预措施

Placebo

Placebo Comparator

Saline solution by target controlled infusion

干预措施: Saline (Drug)

Propranolol at 5ng/ml target dose

Active Comparator

Propranolol iv by target controlled infusion, to achieve a plasmatic concentration of 5ng/ml

干预措施: Propranolol (Drug)

Propranolol at 15ng/ml target dose

Active Comparator

Propranolol iv by target controlled infusion, to achieve a plasmatic concentration of 15ng/ml

干预措施: Propranolol (Drug)

结局指标

主要结局

Postoperative opioid use

时间窗: 24 hours posterior to surgery

Dose of opioid required to manage pain adequately

次要结局

  • Pain thresholds (cold)(24 hours posterior to surgery)
  • Pain thresholds (heat)(24 hours posterior to surgery)
  • Temporal changes in pain sensibility(24 hours posterior to surgery)
  • Pain thresholds (tactile sensitivity)(24 hours posterior to surgery)

研究者

申办方类型
Other
责任方
Sponsor

相似试验